Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Cord Blood Expansion on Mesenchymal Stem Cells

This study has been completed.
Sponsor:
Collaborators:
ViaCell
National Institutes of Health (NIH)
National Cancer Institute (NCI)
Information provided by (Responsible Party):
M.D. Anderson Cancer Center
ClinicalTrials.gov Identifier:
NCT00498316
First received: July 6, 2007
Last updated: October 27, 2016
Last verified: October 2016